GENNEX LABORATORIES
Back to Income Statement
|
GENNEX LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹11 Cr | ₹6.19 Cr | ₹4.11 Cr | ₹4.04 Cr | ₹1.86 Cr |
What is the latest Consolidated Net Profit of GENNEX LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹6.19 Cr |
| Mar2022 | ₹4.11 Cr |
| Mar2021 | ₹4.04 Cr |
| Mar2020 | ₹1.86 Cr |
How is Consolidated Net Profit of GENNEX LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹11 Cr | 83.61 | |
| Mar2023 | ₹6.19 Cr | 50.89 | |
| Mar2022 | ₹4.11 Cr | 1.66 | |
| Mar2021 | ₹4.04 Cr | 117.56 | |
| Mar2020 | ₹1.86 Cr | - | |
Compare Consolidated Net Profit of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹399.1 Cr | 0.5% | 47% | -18.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | 0.5% |
47% |
-18.4% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses